GeneSys Bio

"GeneSys Bio's mission is to pioneer the fight against a wide range of infectious diseases and antibiotic resistance. With our AI-enhanced, PCR-based proprietary technology, we will enable rapid and accurate genetic detection of pathogens in approximately 30 minutes, regardless of location, with no reliance on a cold chain or specialized technical expertise. We will launch our first product in the UTI market by the end of 2025, employing a razor and blades B2B business model."